# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-006914
Filing Date
2024-05-07
Accepted
2024-05-07 07:57:14
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | qure-20240331x10q.htm iXBRL | 10-Q | 1646686
2 | EX-31.1 | qure-20240331xex31d1.htm | EX-31.1 | 15049
3 | EX-31.2 | qure-20240331xex31d2.htm | EX-31.2 | 15058
4 | EX-32.1 | qure-20240331xex32d1.htm | EX-32.1 | 14739
| Complete submission text file | 0001558370-24-006914.txt |  | 6547628

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | qure-20240331.xsd | EX-101.SCH | 41333
6 | EX-101.CAL | qure-20240331_cal.xml | EX-101.CAL | 47706
7 | EX-101.DEF | qure-20240331_def.xml | EX-101.DEF | 229659
8 | EX-101.LAB | qure-20240331_lab.xml | EX-101.LAB | 415014
9 | EX-101.PRE | qure-20240331_pre.xml | EX-101.PRE | 328945
66 | EXTRACTED XBRL INSTANCE DOCUMENT | qure-20240331x10q_htm.xml | XML | 981398

Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 24919674
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)